These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 14518092)

  • 1. [Effect of hypercortisolism on development of atherosclerotic changes in blood vessels].
    Jezková J; Marek J; Prázný M; Krsek M; Malícková K; Rosická M; Jarkovská Z; Pecen L
    Vnitr Lek; 2003 Aug; 49(8):656-67. PubMed ID: 14518092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission.
    Faggiano A; Pivonello R; Spiezia S; De Martino MC; Filippella M; Di Somma C; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2527-33. PubMed ID: 12788849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.
    Colao A; Pivonello R; Spiezia S; Faggiano A; Ferone D; Filippella M; Marzullo P; Cerbone G; Siciliani M; Lombardi G
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2664-72. PubMed ID: 10443657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
    Findling JW; Kehoe ME; Shaker JL; Raff H
    J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal medulla secretion in Cushing's syndrome.
    Mannelli M; Lanzillotti R; Pupilli C; Ianni L; Conti A; Serio M
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1331-5. PubMed ID: 8200934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease.
    Pecori Giraldi F; Andrioli M; De Marinis L; Bianchi A; Giampietro A; De Martin M; Sacco E; Scacchi M; Pontecorvi A; Cavagnini F
    Eur J Endocrinol; 2007 Feb; 156(2):233-9. PubMed ID: 17287413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
    Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
    Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk.
    Tauchmanovà L; Rossi R; Biondi B; Pulcrano M; Nuzzo V; Palmieri EA; Fazio S; Lombardi G
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4872-8. PubMed ID: 12414841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with low IGF-I after curative surgery for Cushing's syndrome have an adverse long-term outcome of hypercortisolism-induced myopathy.
    Vogel F; Braun L; Rubinstein G; Zopp S; Benedix S; Schneider H; Ritzel K; Schilbach K; Schmidmaier R; Beuschlein F; Bidlingmaier M; Reincke M
    Eur J Endocrinol; 2021 May; 184(6):813-821. PubMed ID: 33830940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of nodular thyroid disease in patients with Cushing's disease.
    Invitti C; Manfrini R; Romanini BM; Cavagnini F
    Clin Endocrinol (Oxf); 1995 Sep; 43(3):359-63. PubMed ID: 7586607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth impairment due to transient hypercortisolism.
    Armour K; Chalew S; Kowarski AA
    Acta Endocrinol Suppl (Copenh); 1986; 279():24-8. PubMed ID: 3465164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased autonomic modulation of heart rate and altered cardiac sympathovagal balance in patients with Cushing's syndrome: role of endogenous hypercortisolism.
    Chandran DS; Ali N; Jaryal AK; Jyotsna VP; Deepak KK
    Neuroendocrinology; 2013; 97(4):309-17. PubMed ID: 23327928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma.
    Ambrosi B; Sartorio A; Pizzocaro A; Passini E; Bottasso B; Federici A
    Exp Clin Endocrinol Diabetes; 2000; 108(4):294-8. PubMed ID: 10961361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid action and the clinical features of Cushing's syndrome.
    Yanovski JA; Cutler GB
    Endocrinol Metab Clin North Am; 1994 Sep; 23(3):487-509. PubMed ID: 7805650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of hypercortisolism].
    Rosales C; Fierrard H; Bertagna X; Raffin-Sanson ML
    Rev Med Interne; 2008 Apr; 29(4):337-46. PubMed ID: 18226430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome.
    Ohmori N; Nomura K; Ohmori K; Kato Y; Itoh T; Takano K
    Endocr J; 2003 Feb; 50(1):1-7. PubMed ID: 12733704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtle cognitive impairments in patients with long-term cure of Cushing's disease.
    Tiemensma J; Kokshoorn NE; Biermasz NR; Keijser BJ; Wassenaar MJ; Middelkoop HA; Pereira AM; Romijn JA
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2699-714. PubMed ID: 20371667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Cushing's syndrome in Taiwanese.
    Su DH; Chang YC; Chang TC; Chang CC; Tsai KS; Huang TS
    J Formos Med Assoc; 2003 May; 102(5):292-8. PubMed ID: 12874666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.